LASA

LASA SUPERGENERICS

Small Cap BSE: 540702 NSE: LASA
₹37.65
As on 30 September, 2022 | 01:37

Lasa Supergenerics Share Price

Lasa Supergenerics Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in LASA SUPERGENERICS

Start SIP

Lasa Supergenerics Share Returns

  • Over 1 Month 8.35%
  • Over 3 Month 33.51%
  • Over 6 Month -2.08%
  • Over 1 Year -48.81%

Lasa Supergenerics Key Statistics

P/E Ratio -8.4
PEG Ratio 0
Market Cap Cr 153
Price to Book Ratio 1
EPS 0.6
Dividend 0.7
Relative Strength Index 49.78
Money Flow Index 72.09
MACD Signal 0.83
Average True Range 1.97

Lasa Supergenerics Investment Rating

  • Master Rating:
  • Lasa Supergenerics has an operating revenue of Rs. 129.94 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -5% needs improvement, ROE of -3% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lasa Supergenerics Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 295116343639
Operating Expenses Qtr Cr 374017333130
Operating Profit Qtr Cr -811-1159
Depreciation Qtr Cr 334334
Interest Qtr Cr 000000
Tax Qtr Cr 1-10001
Net Profit Qtr Cr -1212-5-1414

Lasa Supergenerics Technicals

EMA & SMA

Current Price
37.65
(0%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 38.01
  • 50 Day
  • 37.43
  • 100 Day
  • 39.83
  • 200 Day
  • 47.76
  • 20 Day
  • 38.08
  • 50 Day
  • 37.09
  • 100 Day
  • 37.66
  • 200 Day
  • 47.73

Lasa Supergenerics Resistance and Support

PIVOT
₹37.92
Resistance
First Resistance 38.79
Second Resistance 39.92
Third Resistance 40.79
RSI 49.78
MFI 72.09
MACD Single Line 0.83
MACD 0.64
Support
First Resistance 36.79
Second Resistance 35.92
Third Resistance 34.79

Lasa Supergenerics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 45,185 2,662,752 58.93
Week 164,781 8,262,139 50.14
1 Month 198,955 10,852,998 54.55
6 Month 269,267 14,753,156 54.79

Lasa Supergenerics Result Highlights

Lasa Supergenerics Synopsis

NSE-Medical-Ethical Drugs

Lasa Supergenerics is involved in the business activities of Manufacture of veterinary preparations. Company’s Total Operating Revenue is Rs. 137.13 Cr. and Equity Capital is Rs. 40.67 Cr. for the Year ended 31/03/2022. Lasa Supergenerics Ltd. is a Public Limited Listed company incorporated on 11/11/2016 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24233MH2016PLC274202 and registration number is 274202.
Market Cap 153
Sales 130
Shares in Float 2.28
No of funds 1
Yield 0.66
Book Value 1.03
U/D Vol ratio 2.3
LTDebt / Equity
Alpha -0.19
Beta 1.28

Lasa Supergenerics

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 43.78%43.78%45.01%
Foreign Portfolio Investors 0.4%0.06%
Individual Investors 36.74%35.65%30.63%
Others 19.08%20.57%24.3%

Lasa Supergenerics Management

Name Designation
Dr. Omkar Pravin Herlekar Chairman & Managing Director
Mr. Shivanand G Hegde Whole Time Director
Mr. Mithun M Jadhav Whole Time Director
Mr. Hardesh Raja Tolani Independent Director
Ms. Ekta Avtar Gurnasinghani Independent Director
Mr. Ajay Hareshlal Sukhwani Independent Director
Ms. Manali Roop Bhagtani Independent Director

Lasa Supergenerics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lasa Supergenerics Corporate Action

Date Purpose Remarks
2022-08-08 Quarterly Results
2022-04-11 Audited Results & Final Dividend
2022-02-07 Quarterly Results
2021-11-14 Quarterly Results (Revised) per share(2.5%)Final Dividend
2021-08-14 Quarterly Results & A.G.M.

Lasa Supergenerics MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Lasa Supergenerics FAQs

What is Share Price of Lasa Supergenerics ?

Lasa Supergenerics share price is ₹37 As on 30 September, 2022 | 01:23

What is the Market Cap of Lasa Supergenerics ?

The Market Cap of Lasa Supergenerics is ₹153.1 Cr As on 30 September, 2022 | 01:23

What is the P/E ratio of Lasa Supergenerics ?

The P/E ratio of Lasa Supergenerics is -8.4 As on 30 September, 2022 | 01:23

What is the PB ratio of Lasa Supergenerics ?

The PB ratio of Lasa Supergenerics is 1 As on 30 September, 2022 | 01:23

Q1FY23